U.S. FDA Lifts Import Alert on Dr. Reddy’s API Facility in Mexico

Pharmaceutical company Dr. Reddy’s Laboratories (Hyderabad, India) says that the U.S. FDA has lifted the import alert on Industrias Químicas Falcon de México, Dr. Reddy’s wholly owned manufacturing facility at Cuernavaca, Mexico. The facility produces intermediates and active pharmaceutical ingredients (APIs). The lifting of the import alert allows Dr. Reddy’s to start importing products into the U.S. from this facility. The Cuernavaca facility received a warning letter from the FDA in June 2011, following an FDA inspection of...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers